articleTop 1% cited
MULTICENTER RANDOMIZED TRIAL COMPARING TACROLIMUS (FK506) AND CYCLOSPORINE IN THE PREVENTION OF RENAL ALLOGRAFT REJECTION1
Transplantation · 1997 · Vol. 64(3) · pp. 436–443
A. David Mayer(Queen Elizabeth Hospital Birmingham)Jan DmitrewskiJean-Paul Squifflet(UCLouvain)Tatjana Besse(Cliniques Universitaires Saint-Luc)B. Grabensee(Heinrich Heine University Düsseldorf)Barbara C. Klein(Heinrich Heine University Düsseldorf)Friedrich W. Eigler(Medical University of Vienna)Uwe Heemann(Medical University of Vienna)R Pichlmayr✉(Medizinische Hochschule Hannover)Matthias Behrend(Medizinische Hochschule Hannover)Yves VanrenterghemJ DonckJohannes van HooffMaarten H. L. ChristiaansJ.M. Morales(Hospital Universitario 12 De Octubre)Amado Andrés(Hospital Universitario 12 De Octubre)Robert W. Johnson(Manchester Royal Infirmary)Colin D. Short(Manchester Royal Infirmary)B. Buchholz(UCLouvain)Nikola Rehmert(University of Münster)W. Land(Ludwig-Maximilians-Universität München)Stefan Schleibner(Ludwig-Maximilians-Universität München)John Forsythe(Royal Victoria Infirmary)David Talbot(Royal Victoria Infirmary)Hans‐H. Neumayer(Friedrich-Alexander-Universität Erlangen-Nürnberg)I. Häuser(Friedrich-Alexander-Universität Erlangen-Nürnberg)Bo-G ran EriczonChristina Brattstr mKerstin ClaessonFerdinand M hlbacher(Allgemeines Krankenhaus Celle)Erich Pohanka(Allgemeines Krankenhaus Celle)
Abstract
The significant reduction in the incidence of episodes of allograft rejection observed with tacrolimus therapy may have important long-term implications given the prognostic influence of rejection on graft survival.
Renal Transplantation Outcomes and TreatmentsPharmacological Effects and Toxicity StudiesOral and gingival health researchMedicineTacrolimusInternal medicineTransplantationAzathioprineGastroenterologyCiclosporinDiabetes mellitusRandomized controlled trialSurgery
MeSH terms
AdolescentAdultAgedDose-Response Relationship, DrugFemaleGraft RejectionHumansImmunosuppressive AgentsMaleMiddle AgedTransplantation, HomologousKidney TransplantationTacrolimusCyclosporine
Citations
730
FWCI
30.68
field-weighted impact
References
26
Percentile
100%
vs. same field & year
Citations per year
Cited by
NEW-ONSET DIABETES AFTER TRANSPLANTATION: 2003 INTERNATIONAL CONSENSUS GUIDELINES1
Transplantation · 2003 · 678 citations
Incidence and Cost of New Onset Diabetes Mellitus Among U.S. Wait-Listed and Transplanted Renal Allograft Recipients
American Journal of Transplantation · 2003 · 403 citations
Diabetes Mellitus after Kidney Transplantation in the United States
American Journal of Transplantation · 2003 · 1,287 citations
New Onset Diabetes Mellitus in Patients Receiving Calcineurin Inhibitors: A Systematic Review and Meta-Analysis
American Journal of Transplantation · 2004 · 504 citations
SIROLIMUS IN ASSOCIATION WITH MYCOPHENOLATE MOFETIL INDUCTION FOR THE PREVENTION OF ACUTE GRAFT REJECTION IN RENAL ALLOGRAFT RECIPIENTS12
Transplantation · 2000 · 541 citations
SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATION
Transplantation · 1999 · 883 citations
References
MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTS
Transplantation · 1995 · 1,382 citations
LRISK FACTORS FOR CHRONIC REJECTION IN RENAL ALLOGRAFT RECIPIENTS
Transplantation · 1993 · 675 citations
International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology
Kidney International · 1993 · 1,458 citations
A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1
Transplantation · 1996 · 1,061 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.